Trial Profile
Levofloxacin 750mg versus conventional treatment of ceftriaxone and macrolide in community acquired pneumonia: a randomized, open label study - LCMCAP study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2017
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Azithromycin; Ceftriaxone
- Indications Community-acquired pneumonia
- Focus Therapeutic Use
- Acronyms LCMCAP study
- Sponsors Daiichi Sankyo Company
- 18 Apr 2012 New trial record